New disinfectant may slash heart device infections
NCT ID NCT04735666
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether using a disinfectant called TauroPace during heart device surgery can prevent infections. About 2300 patients having procedures like pacemaker placement or replacement are being followed for up to 12 months. The goal is to see if this approach reduces the risk of serious infections around the device.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 2,300 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2021
- Expected to finish
-
Jan 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population consist of every subsequent participant eligible for any CIED related surgery with TauroPace™
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Use of TauroPace™ is indicated and not contra-indicated according to its current Instructions For Use (IFU) * Participant is eligible for a CIED related surgery procedure. Exclusion Criteria: * Age\<18years * Participant incapable of signing Patient Informed Consent (mentally or physically) or does not sign.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cied related infection are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Great Western Hospitals NHS Foundation Trust
Swindon, SN3 6BB, United Kingdom
-
Helios Klinik Cuxhaven
Cuxhaven, Lower Saxony, 27474, Germany
-
Helios Klinik Wesermarsch
Nordenham, Lower Saxony, 26954, Germany
-
Krankenhaus Landshut Achdorf
Landshut, Bavaria, 84036, Germany
-
Landeskrankenhaus Wiener Neustadt
Wiener Neustadt, 2700, Austria
-
Louis Pradel Hospital
Lyon, Bron, 69500, France
-
Ospedale Regionale San Maurizio
Bolzano, Trentino-Alto Adige, 39100, Italy
-
University Hospital Schleswig-Holstein
Kiel, Schleswig-Holstein, 24105, Germany